Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 4 for:    solx
Previous Study | Return to List | Next Study

SOLX Gold Shunt for Refractory Glaucoma

This study has been completed.
Information provided by (Responsible Party):
SOLX, Inc. Identifier:
First received: January 5, 2011
Last updated: April 18, 2016
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2015
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)